M&A Deal Summary

Bridgepoint Acquires Quotient Sciences

On December 11, 2013, private equity firm Bridgepoint acquired life science company Quotient Sciences from Quotient Bioresearch

Acquisition Highlights
  • This is Bridgepoint’s 3rd transaction in the Life Science sector.
  • This is Bridgepoint’s 41st transaction in the United Kingdom.
Investment Fate
  • Quotient Sciences was sold to a consortium of financial buyers in 2015.
  • Quotient Sciences was recapitalized in 2019.

M&A Deal Summary

Date 2013-12-11
Target Quotient Sciences
Sector Life Science
Buyer(s) Bridgepoint
Sellers(s) Quotient Bioresearch
Deal Type Divestiture

Target

Quotient Sciences

Nottingham, United Kingdom
Quotient Sciences is a provider of outsourced, early-stage drug development services to the pharmaceutical industry. Quotient Sciences has brought innovation to the pharmaceutical services sector through its unique Translational Pharmaceutics® platform, which is proven to accelerate development timelines, reduce development costs, and drive improvement in R&D productivity. Quotient Sciences was founded in 1990 and is based in Nottingham, England.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Bridgepoint

London, United Kingdom

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1984
PE ASSETS 75.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Bridgepoint is a large European private equity firm that invests in middle-market companies across a broad range of industries with an enterprise value of €200 - €1000 million. Prospective transaction situations include buyouts, buy-ins, growth financings, consolidations, and take privates. The firms invest in the range of €75 - €400 million transaction. Bridgepoint Development Capital specializes in investments in businesses valued up to a €150 million, taking equity stakes of between €10 million and €75 million. General sectors of interest include consumer products and services, retail, financial services, healthcare, media, technology, industrials, and business services. Bridgepoint was formed in 1984 and has offices in London, Frankfurt, Luxembourg, Madrid, Milan, Paris, Stockholm and Warsaw.


DEAL STATS #
Overall 91 of 188
Sector: Life Science M&A 3 of 6
Type: Divestiture M&A Deals 10 of 20
Country: United Kingdom M&A 41 of 81
Year: 2013 M&A 9 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-04 Cambridge Education Group

Cambridge, United Kingdom

Cambridge Education Group is a provider of pre-university and English language teaching in the UK. The group teaches a mix of overseas and UK students at Foundation, GCSE, A Level and International Baccalaureate levels. Cambridge Education Group was founded in 1952 and is based in Cambridge, United Kingdom.

Buy £185M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-01 Nextpool

Ecully, France

Nextpool provides design, manufacturing, and delivery of bespoke swimming pool equipment. The company’s product positioning is mid/high-end, and its clientele is entirely B2B. Its products include swimming pool safety covers, swimming pool liners, water treatment products, and sun protection equipment. Nextpool was formed in 2004 and is based in Ecully, France.

Sell -

Seller(S) 1

SELLER

Quotient Bioresearch

Rushden, United Kingdom

Category Company
Founded 1992
Sector Life Science
Employees200
DESCRIPTION

Quotient Bioresearch Ltd. is a provider of radiochemistry and drug metabolism solutions for the pharmaceutical, agrochemical and chemical industries.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2013 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-02 Quotient Sciences

Nottingham, United Kingdom

Quotient Sciences is a provider of outsourced, early-stage drug development services to the pharmaceutical industry. Quotient Sciences has brought innovation to the pharmaceutical services sector through its unique Translational Pharmaceutics® platform, which is proven to accelerate development timelines, reduce development costs, and drive improvement in R&D productivity. Quotient Sciences was founded in 1990 and is based in Nottingham, England.

Buy -